Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Sampling
The use of a statistically representative subset as a proxy for an entire population, for example in order to facilitate quantitative market research.
The main benefits of sampling are that the cost is reduced, data collection is quicker, and due to the decreased quantity of a population subset, the procurred data allows uniformity and improvement in precision quality information.
See also:
Quantitative research
Data Collection
Random samplings
Related terms
Open ended question, Research and development (R&D), Infant, Product class, Adoption curve, Comparative advertising, Greying, leisured, affluent, middle-aged (GLAM), Omnibus survey, Focused Advertising Sampling Technique (FAST) Marketing, Launch, Adopter categories, Strategic business unit (SBU), Respondent, External analysis, Respondent fatigue,
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- bluebird bio reveals plans to launch two gene therapies
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- Eli Lilly to make bebtelovimab commercially available to US states from August
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- ONS records a continued fall in UK COVID-19 infections
- Regeneron terminates four clinical trials of its COVID-19 antibody cocktail REGEN-COV
- My body. My choice. Are we all talking about the same thing?
- BeiGene announces positive phase 3 trial results for liver cancer treatment
- Sanofi halts recruitment for trials assessing MS treatment
- Merck and Cerevance to research novel targets in Alzheimer’s disease
- Michael J Fox Foundation awards Koneksa second research grant
- FDA approves Bot Image’s AI software for the detection and diagnosis of prostate cancer
- GSK/Merck KGgA cancer drug fails in third trial
- GSK’s ViiV and Medicines Patent Pool agree deal for HIV prevention
- Avastin wins EU approval for advanced renal cancer
- Chiesi Group's Trimbow wins European licence
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- Merck and Cerevance to research novel targets in Alzheimer’s disease
